<DOC>
	<DOCNO>NCT00966095</DOCNO>
	<brief_summary>The purpose study develop validate blood-based diagnostic test predict prostate biopsy outcome positive negative prostate cancer . Such test serve reduce number unnecessary prostate biopsy .</brief_summary>
	<brief_title>PRostate Cancer Individual Signature Evaluation Trial Patients Undergoing Scheduled Prostate Biopsy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>. 1 . Male age 40 . 2 . Patient schedule prostate biopsy one follow reason : PSA &gt; 2.5 ng/ml Rising PSA ( &gt; 0.5 ng/ml/yr ) Lower PSA value risk factor prostate cancer ( e.g . ; family history ) Abnormal DRE Percent free PSA &lt; 15 % 3 . No prior history prostate cancer prostate biopsy . Unable unwilling provide inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>prostate cancer</keyword>
</DOC>